Diabetes is a growing global health issue. Type 2 diabetes (T2D) is particularly challenging. Managing it requires innovative treatments. One such treatment is Glyxambi. It combines empagliflozin and linagliptin. This article examines its efficacy in T2D management. The focus is on its benefits, limitations, and place in modern treatment strategies. The Role of Alphaproteinase Inhibitor […]